Gastrointestinal effects are the most frequently reported side effects and include: Nausea (1224% of patients): Often most pronounced during treatment initiation and dose escalation, typically improving over time Diarrhea (1323% of patients): May be transient or persistent, requiring dietary modifications Vomiting (611% of patients): Can lead to dehydration if severe or prolonged Constipation (617% of patients): May require increased fiber intake and hydration Abdominal pain or discomfort (610% of patients): Usually mild to moderate in severity Decreased appetite : Therapeutic effect but may be excessive in some individuals These gastrointestinal symptoms generally diminish over several weeks as the body adjusts to the medication
Tirzepatide Compounded with B12 Understanding the Concern: Will Medical Weight Loss Make Me Sick
Most patients experience gastrointestinal effects in weeks 14, with symptom severity and duration varying widely
O'Brien et al., 2012)
Because terminology, peptide form, assay design, and reporting quality vary across the historical literature, study conclusions should remain tied to the exact sequence, disulfide configuration, counterion or salt form, formulation, species, route, exposure period, and endpoint used
10.1016/s0899-9007(00)00421-4 38 LarssonA.EngelJ